Depression in major neurodegenerative diseases and strokes: a critical review of similarities and differences among neurological disorders
J Pagonabarraga, C Álamo, M Castellanos, S Díaz… - Brain Sciences, 2023 - mdpi.com
Depression and anxiety are highly prevalent in most neurological disorders and can have a
major impact on the patient's disability and quality of life. However, mostly due to the …
major impact on the patient's disability and quality of life. However, mostly due to the …
Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation
Parkinson's disease (PD) is characterized by motor and non-motor symptoms associated
with dopaminergic and non-dopaminergic injury. Vortioxetine is a multimodal serotonergic …
with dopaminergic and non-dopaminergic injury. Vortioxetine is a multimodal serotonergic …
Vortioxetine improves depressive symptoms and cognition in Parkinson's disease patients with major depression: an open-label prospective study
D Santos García, MG Alonso Losada… - Brain Sciences, 2022 - mdpi.com
Depression is frequent in Parkinson's disease (PD) patients, but the evidence for many
antidepressant agents to treat it in PD is insufficient. The aim of the present prospective open …
antidepressant agents to treat it in PD is insufficient. The aim of the present prospective open …
[HTML][HTML] Расстройства депрессивного спектра в неврологической практике: есть ли место под солнцем, или кто должен лечить пациентов?
АВ Анцыборов, ИВ Дубатова - Интерактивная наука, 2021 - cyberleninka.ru
При большинстве неврологических заболеваний симптомы депрессии оказывают
значимое влияние на ухудшение качества жизни пациентов, вне зависимости от …
значимое влияние на ухудшение качества жизни пациентов, вне зависимости от …